Demis Hassabis on Isomorphic’s $600 million raise, AI, and healthcare’s future
Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...
DeepMind is holding back release of AI research to give Google an edge
Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...
DeepMind slows down research releases in battle to keep competitive edge
Google’s AI arm led by Demis Hassabis makes it harder for its researchers to publish studies in major change in approach ...
Silicon Canals18h
Alphabet spinout Isomorphic Labs secures €555.4M to further transform drug discovery with AI
Isomorphic Labs was founded to apply artificial intelligence to drug discovery. The company is led by AI researcher Sir Demis Hassabis.
Investing.com Canada22h
Google’s DeepMind slows research publications to maintain AI edge – FT
Investing.com-- Google’s (NASDAQ: GOOGL) artificial intelligence research arm, DeepMind, has imposed stricter controls on the ...
Google-backed AI drug discovery startup raises $600 million
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
Explore more
Endpoints News12h
Q&A: Demis Has­s­abis talks 'tur­bocharg­ing' Iso­mor­phic with $600M, ex­pand­ing in­to an­ti­bod­ies and the US
Isomorphic Labs CEO Demis Hassabis discusses $600M funding round, plans for a US office, and expanding into ...
The Daily Upside16h
Google-Backed AI Drug-Developer Isomorphic Labs Secures $600 Million
Though Isomorphic is burning through millions in R&D costs now, investors have high hopes for the potential of AI drug ...